Plasma treatment for a rare eye condition from Type 1 deficiency
Part of Eyes & vision clinical trials.
This trial studies donated blood-plasma samples as a treatment for ligneous conjunctivitis caused by Type 1 plasminogen deficiency. It may help reduce or improve the eye inflammation and growths linked to this specific genetic problem.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ligneous conjunctivitis.
- Your cause is Type 1 plasminogen deficiency (a specific protein deficiency).
- Your eye condition must allow you to use the study treatment safely.
- You do not have another eye problem at the same time that would block study drug use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial provides access to a treatment for people with ligamentous laxity caused by a rare enzyme problem called plasminogen deficiency. The aim is to offer the treatment to a small group while gathering more information.
This trial tests a gene therapy called LX107 for people with vision loss caused by changes in the AIPL1 gene. It aims to see if the treatment is safe and can improve vision.
This trial tests whether an injection of a special concentrate from your own blood (platelet-rich plasma, or PRP) can help calm severe dry eye disease. It’s meant for people whose dry eye has not improved with other treatments.
This study looks at people diagnosed with type 1 plasminogen deficiency (a condition with low plasminogen levels) and can also include their first-degree family members. It may help researchers learn more about the condition and how to monitor it over time by collecting blood and genetic information.
This study compares two types of blood-derived treatments (a growth-factor enriched plasma product versus your own serum) to see which helps corneal cells heal better in people with aniridia. It may be helpful if you need improved cornea healing, but you must meet blood-safety and eye-sample requirements.
This study tests a treatment made from your own blood (called PRGF) to see if it helps people with severe dry eye disease. The treatment uses growth factors from your blood to help heal and lubricate your eyes.
Hear when a new Ligneous Conjunctivitis, Left Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.